🔎 Trials Near Me

Utama › Kanser Paru-paru Bukan Sel Kecil › Kansas › Kansas City

Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Kansas City, KS

11 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Kansas City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Mengambil pesertaFasa 1
  • University of Kansas Medical Center, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06343402

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Mengambil pesertaFasa 3
  • University of Kansas Cancer Center, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06500481

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • The University of Kansas Cancer Center, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Mengambil pesertaFasa 1
  • The University of Kansas Hospital, Kansas City
  • The University of Kansas Medical Center Medical Office Building, Kansas City
  • University of Kansas Hospital Cambridge North Tower A, Kansas City
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Jul 2026 · NCT04389632

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • University of Kansas Cancer Center, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • University of Kansas Cancer Center, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2/3
  • University of Kansas Cancer Center, Kansas City
  • Veteran Administration Eastern Kansas Healthcare, Leavenworth · 21 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • University of Kansas Cancer Center, Kansas City
18 Minutes · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06031688

Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC

Mengambil pesertaFasa 1/2
  • The University of Kansas Cancer Center, Westwood Campus, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Jan 2026 · NCT04467723

Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients

Mengambil pesertaKajian pemerhatian
  • The University of Kansas Cancer Center, Westwood Campus, Kansas City
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Mei 2024 · NCT04680377

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

Mengambil pesertaKajian pemerhatian
  • The University of Kansas Cancer Center, Westwood Campus, Kansas City
Umur 18 hingga 110 · Semua jantina · Dikemas kini 23 Feb 2024 · NCT05332925

Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain

Kajian lain di Kansas City

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.